Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy

Seuss+ CEO and Co-Founder Sabine Hutchison delves into the remarkable growth strategy and remarkable journey of Agenus Bio, a standout player in the competitive Biotech industry. This unique organization chooses to be purposefully different. Jennifer reveals the story behind their success, discussing the importance of in-house capabilities, a patient-focused approach, and strategic collaborations that have set them apart in this heavily regulated field. Sabine and Jennifer explore the captivating world where science and creativity unite. Discover their secrets to success and get inspired by the boundless possibilities that emerge when these two forces intertwine. Tune in for a riveting discussion that illuminates the path to a future shaped by the transformative synergy of science and creativity in biotechnology.Jennifer Buell – BioDr. Jennifer Buell is the Chairman, Executive Council at Agenus and the President and CEO at MiNK Therapeutics, with over 27 years of biopharmaceutical experience. She has led teams through discovery to clinical development and commercialization. Previously, she served as President and COO at Agenus, overseeing research, clinical development, manufacturing, and more, transforming the company into a global biotech with strategic partnerships. Before that, she held leadership positions at Bristol-Myers Squibb and Harvard Clinical Research Institute (Baim), contributing to development strategies for clinical programs. Dr. Buell earned her Ph.D. in Cellular, Biochemical, and Molecular Biochemistry, along with an M.S. in Biostatistics from Tufts University.Join the discussion and listen to the full episode here.